Top 10 Biotech Angel Investors in Belgium in January 2026
A list of 10 angel investors that invest in Biotech startups based in Belgium. We rank investors based on the number of investments they made in Biotech companies from Belgium. We update this investor list every month.Top 10 Biotech Angel Investors in Belgium in January 2026
| Investor | Biotech Belgium investments |
|---|---|
| Annie Vereecken | 3 |
| Pierre Drion | 3 |
| Luc Vauterin | 2 |
| Virginie Saverys | 1 |
| Evren Ucok | 1 |
| Patrick Keereman | 1 |
| Yves Beudin | 1 |
| Jean Dessain | 1 |
| Kenneth Buckfire | 1 |
| Herman Verrelst | 1 |
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Venture Capital
Sustainability
Clean Energy
Web3
Art
Organic Food
Big Data
Wellness
Video Games
Publishing
B2B
Food and Beverage
Payments
Real Estate
Finance
Education
Financial Services
Retail
Infrastructure
Beauty
Photography
Android
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Mobile Advertising
Platforms
Cannabis
Automotive
Social
Wine And Spirits
Medical Device
Crowdfunding
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
Digital Media
LGBT
Manufacturing
Construction
Sports
Oil and Gas
Fashion
Franchise
Film
Life Science
Theatre
eSports
Non Profit
Mobile
Enterprise Software
Music
Email
Social Media
Social Network
Renewable Energy
SaaS
Sporting Goods
Medical
Restaurants
Social Impact
Software
Celebrity
Legal
Cryptocurrency
Local
Internet
Machine Learning
Blockchain
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Ghana
Singapore
Egypt
Belarus
Spain
Hungary
China
Finland
France
Armenia
Croatia
Saudi Arabia
Gibraltar
Barbados
Georgia
Oceania
Greece
Czech Republic
Faroe Islands
Costa Rica
Hong Kong
Africa
Bahrain
Belgium
Denmark
Bermuda
Estonia
Algeria
Ecuador
Bulgaria
LATAM
Belize
Chile
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Liberia
Jersey
Asia
Lebanon
Norway
Mexico
Brazil
Italy
Mali
Philippines
Israel
Togo
Kuwait
Mauritius
Rwanda
Malta
Morocco
Nicaragua
Slovenia
Dominican Republic
Poland
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
Uganda
United Arab Emirates
Jamaica
Honduras
San Marino
Isle of Man
Bolivia
Sweden
Luxembourg
Serbia
Pakistan
Albania
Sierra Leone
Thailand
Tanzania
Romania
Jordan
Uzbekistan
Grenada
Argentina
Bangladesh
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Kazakhstan
Kenya
Cayman Islands
Ukraine
Cambodia
Taiwan
Cyprus
Oman
Latvia
Colombia
Cameroon
Austria
Switzerland
Guatemala
Seychelles
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Hospitality
Mobile Advertising
FinTech
Automotive
Enterprise
Health Care
Biotech
Climate
SaaS
Community
Retail
Gaming
Real Estate
Publishing
Transportation
Payments
Legal
Platforms
Proptech
Hardware
Artificial intelligence
Media (entertainment)
Construction
Machine Learning
Energy
Consumer
Mobile